2027 ICD-10-CM Diagnosis Code T38.2X5SAdverse effect of antithyroid drugs, sequela

ICD-10-CM T38.2X5S

CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

T38.2X5S is a billable ICD-10-CM diagnosis code for adverse effect of antithyroid drugs, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 922 through 923. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code

T38.2X5S

Billable Status

Yes — Valid for Submission

Code Describes

Adverse effect of antithyroid drugs, sequela

Short Description

Adverse effect of antithyroid drugs, sequela

Same as the full description in the CMS dataset.

Parent Code

T38.2X5

Adverse effect of antithyroid drugs

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes

SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances

CategoryT38Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified

This CodeT38.2X5SAdverse effect of antithyroid drugs, sequela

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T38.2X5S.

Unacceptable principal diagnosis

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

T38.2X5S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review the other POA exempt codes in Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50).

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

Acquired pancytopenia
Adverse reaction to thiourea
Agranulocytosis
Agranulocytosis caused by antithyroid agent
Antithyroid drug adverse reaction
Carbimazole adverse reaction
Hyperthyroidism secondary to potassium iodide
Iodine-induced hyperthyroidism
Pancytopenia caused by antithyroid drug
Pancytopenia caused by medication
Propylthiouracil adverse reaction
Thiouracil antithyroid agent adverse reaction
Thyroid disease monitoring status
Thyroid drug side effects
Thyroiditis caused by ionizing radiation due to and following iodine 131 treatment

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the applicable episode of care:

A - initial encounter
D - subsequent encounter
S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to T38.2X5S: its own notes plus those printed at T38, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.